Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 1
2009 3
2010 1
2011 2
2012 2
2013 1
2014 6
2015 5
2016 10
2017 8
2018 6
2019 12
2020 10
2021 11
2022 10
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Rationale and design for the randomized placebo-controlled double-blind trial studying the effect of single antiplatelet therapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty (CLEAR-PATH).
Wegerif ECJ, Ünlü Ç, Generaal MI, van den Bor R, van de Ven PM, Bots ML, de Borst GJ. Wegerif ECJ, et al. Among authors: unlu c. Am Heart J. 2024 Apr 10:S0002-8703(24)00080-2. doi: 10.1016/j.ahj.2024.04.001. Online ahead of print. Am Heart J. 2024. PMID: 38608997 Free article.
The Dutch chronic lower limb-threatening ischemia registry (THRILLER): A study protocol for popliteal and infrapopliteal endovascular interventions.
Nugteren MJ, Hazenberg CEVB, Akkersdijk GP, Bakker OJ, Dinkelman MK, Fioole B, van den Heuvel DAF, Heyligers JMM, Hinnen JW, Pierie M, Schouten O, Schreve MA, Verhoeven BAN, de Borst GJ, Ünlü Ç. Nugteren MJ, et al. Among authors: unlu c. PLoS One. 2023 Jul 20;18(7):e0288912. doi: 10.1371/journal.pone.0288912. eCollection 2023. PLoS One. 2023. PMID: 37471351 Free PMC article.
A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol.
Alozai T, Lam YL, Schreve MA, de Smet AA, Vahl AC, Terlouw-Punt LC, Ünlü Ç, Wittens CH. Alozai T, et al. Among authors: unlu c. Phlebology. 2023 Sep;38(8):532-539. doi: 10.1177/02683555231189414. Epub 2023 Jul 12. Phlebology. 2023. PMID: 37436708 Clinical Trial.
85 results